MFN2 and metabolic dysfunction-associated steatohepatitis: Accordingly, liver‐specific ablation of MFN‐2, which triggers defective mitochondrial fusion, modified PS transfer and phospholipid synthesis, and leads to the development of NASH‐like hyperlipidemia (Hernandez‐Alvarez et al, 2019).